Arthritis Research UK and the IKC have joined together to offer proof of concept funding to progress research ideas with commercial potential.
The Proof of Concept Awards will provide support with funding of up to £100,000 to accelerate exciting innovations that support the lives of people with musculoskeletal conditions.
Proposals will be accepted from scientists, clinicians and allied healthcare professionals at eligible UK institutions; collaborations with industry are also welcomed.
Applications will be judged on the clinical need, potential market opportunity and industry confidence to progress and support the technology to market.
The charity, the biggest funder of research into the cause, treatment and cure of all forms of arthritis in the UK, has joined forces again with the national Medical Technologies Innovation and Knowledge Centre to access expertise in, product development, speeding up the route to market and reducing the risk of late-stage failure.
The funding is intended to develop or evaluate innovative technologies that help support individuals suffering from musculoskeletal conditions; in particular, projects that develop the following:
- Medical devices
- Implantable therapeutic delivery
Deadline: Expressions of interest by 11 December 2017
The maximum support that can be requested: £100,000.
Further information is available from the Arthritis Research UK website